Table 1. The clinical and demographic characteristics of HCC cases and clinical controls.
HCC patients |
Healthy Controls |
||||
---|---|---|---|---|---|
N | % | N | % | ||
Age | |||||
50-54 | 2 | 10.53 | 3 | 15.79 | |
55-59 | 5 | 26.32 | 5 | 26.32 | |
60-64 | 4 | 21.05 | 4 | 21.05 | |
65-69 | 5 | 26.32 | 3 | 15.79 | |
70-74 | 3 | 15.79 | 3 | 15.79 | |
75-79 | 0 | 0 | 1 | 5.26 | |
Gender | |||||
Male | 17 | 89.47 | 17 | 89.47 | |
Female | 2 | 10.53 | 2 | 10.53 | |
Tumor Stage | |||||
I | 10 | 52.63 | 0 | 0 | |
II | 0 | 0 | 0 | 0 | |
III | 8 | 42.05 | 0 | 0 | |
ⅢA | 1 | 5.26 | 0 | 0 | |
ⅢB | 1 | 5.26 | 0 | 0 | |
ⅢC | 6 | 31.58 | 0 | 0 | |
IV | 1 | 5.26 | 0 | 0 | |
Clinical settings combined | |||||
HBsAg (+) | 17 | 89.47 | 0 | 0 | |
Anti-HCV (+) | 0 | 0 | 0 | 0 | |
Liver cirrhosis | 18 | 94.74 | 0 | 0 |